Primary overall survival analysis from the Phase 3 monarchE study of Verzenio (abemaciclib) in HR+HER2-, node-positive, high-risk early breast cancer to be presented as a late-breaking oral ...
Bristol Myers Squibb (NYSE: BMY) today announced the presentation of data across its oncology portfolio and pipeline at the European Society for Medical Oncology (ESMO) Congress 2025 to be held from ...
Plug Power’s stock is extending its recent surge as investors look to how a hydrogen producer can be an artificial-intelligence play. Shares of Plug Power Inc. have blasted higher in recent weeks, as ...
KPRC 2 Investigates repeat power outages in the Houston area. How to check power outages in your zip code. (Copyright 2025 by KPRC Click2Houston - All rights reserved ...
MEMPHIS—For Elon Musk, ground zero of the artificial intelligence arms race is a 114-acre tract of grass and swamp on the state line of Tennessee and Mississippi. This once-sleepy plot of land, filled ...
As artificial intelligence usage soars, so has demand for data centers to power it. Cities are grappling with what that means for their residents’ electricity bills and the reality of living in the ...
Nvidia makes the chips that support artificial intelligence, making it something of a picks-and-shovels play on AI. AI needs to "live" somewhere, which favors real estate investment trusts. AI needs ...
ParkMobile has finally wrapped up a class action lawsuit over the platform's 2021 data breach that hit 22 million users. But there's a catch: victims are receiving compensation in the form of a $1 ...
This is read by an automated voice. Please report any issues or inconsistencies here. The Supreme Court’s new term opens Monday. The overriding question confronting the justices: Are there any legal ...
The industry believes AI will work its way into every corner of our lives, and so needs to build sufficient capacity to address that anticipated demand. But the hardware used to make AI work is so ...
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB) , a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback